Results 11 to 20 of about 113,965,924 (221)

No Evidence of HPAI H5N1 in Coastal Areas of Australia's Antarctic Territory During the 2025/26 Austral Summer. [PDF]

Influenza Other Respir Viruses
Influenza and Other Respiratory Viruses, Volume 20, Issue 9, September 2026.
Emmerson L, McLatchie M, Williams JL, Day J, Riaz J, Southwell C, Wille M.   +6 more
europepmc   +2 more sources

H5N1 Clade 2.3.4.4b Infections in Domestic Cats During an Avian Influenza Outbreak in Italy: Implications for One Health Surveillance. [PDF]

Influenza Other Respir Viruses
ABSTRACT Background H5Nx goose/Guangdong (Gs/GD) lineage highly pathogenic avian influenza (HPAI) viruses pose a significant public health threat due to their global spread, mutation accumulation, and expanding host range. The descendant clade 2.3.4.4b has been causing widespread infections in birds and increasing spillover events in mammals.
D'Annunzio G, Moreno A, Tosi G, Bassi P, Bortolami A, Diegoli G, Drago A, Fusaro A, Gelmini L, Gibelli LR, Lazzarotto T, Lilliu E, Piccolomini LL, Maroni A, Martini E, Matteo G, Mattei G, Muscatello LV, Monne I, Palumbo E, Prezzemolo G, Ravaioli V, Resi D, Ruocco L, Sabatino MO, Savegnago E, Sordilli M, Terregino C, Tolini C, Merialdi G.   +29 more
europepmc   +2 more sources

A comparison of clinical and epidemiological characteristics of fatal human infections with H5N1 and human influenza viruses in Thailand, 2004-2006. [PDF]

PLoS ONE, 2011
BACKGROUND: The National Avian Influenza Surveillance (NAIS) system detected human H5N1 cases in Thailand from 2004-2006. Using NAIS data, we identified risk factors for death among H5N1 cases and described differences between H5N1 and human (seasonal ...
Vivek Shinde, Wanna Hanshaoworakul, James M Simmerman, Ubolrat Narueponjirakul, Wiwan Sanasuttipun, Suchada Kaewchana, Darin Areechokechai, Kumnuan Ungchusak, Alicia M Fry   +8 more
doaj   +1 more source

Assessment of Serosurveys for H5N1 [PDF]

Clinical Infectious Diseases, 2013
It has been suggested that the true case-fatality rate of human H5N1 influenza infection is appreciably less than the figure of approximately 60% that is based on official World Health Organization (WHO)-confirmed case reports because asymptomatic cases may have been missed.
Eric S, Toner, Amesh A, Adalja, Jennifer B, Nuzzo, Thomas V, Inglesby, Donald A, Henderson, Donald S, Burke   +5 more
openaire   +2 more sources

Serological evidence of human infections with highly pathogenic avian influenza A(H5N1) virus: a systematic review and meta-analysis

BMC Medicine, 2020
Background Highly pathogenic avian influenza A(H5N1) virus poses a global public health threat given severe and fatal zoonotic infections since 1997 and ongoing A(H5N1) virus circulation among poultry in several countries.
Xinhua Chen, Wei Wang, Yan Wang, Shengjie Lai, Juan Yang, Benjamin J. Cowling, Peter W. Horby, Timothy M. Uyeki, Hongjie Yu   +8 more
doaj   +1 more source

PA from a Recent H9N2 (G1-Like) Avian Influenza A Virus (AIV) Strain Carrying Lysine 367 Confers Altered Replication Efficiency and Pathogenicity to Contemporaneous H5N1 in Mammalian Systems

Viruses, 2020
Egypt is a hotspot for H5- and H9-subtype avian influenza A virus (AIV) infections and co-infections in poultry by both subtypes have been frequently reported. However, natural genetic reassortment of these subtypes has not been reported yet.
Ahmed Mostafa, Sara H. Mahmoud, Mahmoud Shehata, Christin Müller, Ahmed Kandeil, Rabeh El-Shesheny, Hanaa Z. Nooh, Ghazi Kayali, Mohamed A. Ali, Stephan Pleschka   +9 more
doaj   +1 more source

Heterosubtype neutralizing responses to influenza A (H5N1) viruses are mediated by antibodies to virus haemagglutinin. [PDF]

PLoS ONE, 2009
BACKGROUND:It is increasingly clear that influenza A infection induces cross-subtype neutralizing antibodies that may potentially confer protection against zoonotic infections. It is unclear whether this is mediated by antibodies to the neuraminidase (NA)
Jean-Michel Garcia, Stephanie Pepin, Nadège Lagarde, Edward S K Ma, Frederick R Vogel, Kwok H Chan, Susan S S Chiu, J S M Peiris   +7 more
doaj   +1 more source

MVA-based H5N1 vaccine affords cross-clade protection in mice against influenza A/H5N1 viruses at low doses and after single immunization. [PDF]

, 2009
Human infections with highly pathogenic avian influenza viruses of the H5N1 subtype, frequently reported since 2003, result in high morbidity and mortality.
Sutter, G. (Gerd), Sutter Gerd, Rimmelzwaan, Guus F., Osterhaus, A.D.M.E. (Albert), Yasemin Suezer, Gerrie de Mutsert, Suezer, Yasemin, Geert van Amerongen, Löwer, Johannes, Fouchier Ron A. M., Osterhaus, Albert D. M. E., Kreijtz, Joost H. C. M., Mutsert, Gerrie de, Fouchier, Ron A. M., Fouchier, R.A.M. (Ron), Guus F Rimmelzwaan, van den Brand Judith M. A., Löwer Johannes, Johannes Löwer, Kreijtz, J.H.C.M. (Joost), Suezer, Y., Judith M A van den Brand, Suezer Yasemin, Mutsert, G. (Gerrie) de, Amerongen, G. (Geert) van, Rimmelzwaan Guus F., Brand, J.M.A. (Judith) van den, Joost H C M Kreijtz, Sutter, Gerd, Schwantes, Astrid, de Mutsert Gerrie, Brand, Judith M. A. van den, Osterhaus Albert D. M. E., Schwantes Astrid, Scwantes, A. (Astrid), Ron A M Fouchier, van Amerongen Geert, Albert D M E Osterhaus, Gerd Sutter, Astrid Schwantes, Rimmelzwaan, G.F. (Guus), Kreijtz Joost H. C. M., Amerongen, Geert van, Löwer, J., Fouchier, Ron A.M.; id_orcid, Scwantes, Astrid, van Amerongen, Geert, van den Brand, Judith M.A., Osterhaus, Albert D.M.E., Kreijtz, Joost H.C.M., de Mutsert, Gerrie   +50 more
core   +1 more source

COMPARATIVE ANALYSIS OF PATHOGENICITY OF INFLUENZA A(H5N1) AND A(H1N1)pdm09 VIRUSES IN MICE

Журнал микробиологии, эпидемиологии и иммунобиологии, 2018
Aim. Compare the degree of pathogenicity of newly emerging influenza virus strains with pandemic potential by experimental infection of BALB/c mice with highly pathogenic avian influenza A(H5N1) virus and mouse adapted pandemic influenza A(H1N1)pdm09 ...
E. A. Prokopeva, K. A. Sharshov, A. A. Romanovskaya, I. A. Sobolev, O. G. Kurskaya, E. I. Soloveva, L. V. Shestopalova, A. V. Zaykovskaya, A. Yu. Alekseev, A. M. Shestopalov   +9 more
doaj   +1 more source

H5N1 whole-virus vaccine induces neutralizing antibodies in humans which are protective in a mouse passive transfer model. [PDF]

PLoS ONE, 2011
Vero cell culture-derived whole-virus H5N1 vaccines have been extensively tested in clinical trials and consistently demonstrated to be safe and immunogenic; however, clinical efficacy is difficult to evaluate in the absence of wide-spread human disease.
M Keith Howard, Nicolas Sabarth, Helga Savidis-Dacho, Daniel Portsmouth, Otfried Kistner, Thomas R Kreil, Hartmut J Ehrlich, P Noel Barrett   +7 more
doaj   +1 more source